23948sdkhjf

Meet the governmental life science office

| Av Hanna Brodda | Tipsa redaktionen

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duties of the Life Sciences office are plentiful.

A few doors away from Vinnova at Mäster Samuelsgatan in Stockholm, in the premises of the Näringsdepartementet (the Swedish Ministry of Industry), you will find an office that may make a significant difference to Swedish medical technology in the next few years – the Life Sciences office.

Head of the office, Jenni Nordborg, is working here three days a week, and today is one of those days. When we meet, it has been almost two months since the election of 2018, which turned out to be the beginning of an autumn of great parliamentary uncertainty. The government that will eventually be installed in Rosenbad, Sweden’s seat of government, will have many crucial decisions to make. One of them is how the coordination function of the newly established Life Sciences office is to advance their work in the future.

– We still need to work in this manner. There is an awareness that we need to collaborate to get a more efficient functioning life sciences sector in Sweden. With everything from health and care, a competitive export industry with high-quality jobs, education and research issues, this is a complex area that transversally affects many ministries, explains Jenni Nordborg, who still has her half-time job as Head of Health at Sweden’s innovation agency Vinnova.

The Life Sciences office was commissioned by the Social-Democratic Government in February after the former Life Sciences Coordinator Anders Lönnberg (S) presented the proposal. The Swedish Life Sciences office is modelled after the Office for Life Sciences, placed directly under the British Government. Today, the Office for Life Sciences has been established and carries out its duties regardless of the Prime Minister or leading party.

The Swedish office was assigned the task of promoting the development of knowledge, innovation and quality in healthcare, the care sector and at universities and colleges. The office also undertakes to improve the conditions for life sciences companies that set out to establish themselves and work in Sweden.

– Other countries work in a similar manner, Denmark for example, says Nordborg.

The Swedish Life Sciences office consists of several officials from the Näringsdepartementet (the Ministry of Enterprise and Innovation), the Utbildningsdepartementet (the Ministry of Education and Research) and the Socialdepartementet (the Ministry of Health and Social Affairs).

The duties vary, but concern matters regarding health, care, research, export and investment. One of the major tasks for Jenni Nordborg this autumn has been to provide the basis for a national life sciences strategy. She accomplishes this by listening and collecting suggestions and opinions from all fields; academia, business, patient and care.

– Life sciences is not just a job for the government and the national level, but it is vital that they participate and take responsibility together with county councils, municipal principals, industry and academia, and together with the patients.

Is the office sufficiently staffed to be able to accomplish the task?

– In my opinion, we will need an even more distinct capacity function in the future, but this coordination team is an adequate solution right now.

What political initiatives are you hoping for?

– In the future, we will see an increasing need for innovative treatment methods, as well as preventive solutions. We see that medical technology and diagnostics are combined with brand new digital working methods and new drugs - making the life sciences sector a future industry. However, global competition is tough. The provision of skills and lifelong learning play a crucial role. Many inputs to our strategy work are about ways to improve our capabilities in system innovation and the use of data, as well as access to our leading and central infrastructures that we actually do have.

Is the care sector behind you?

– Yes, it would not be possible without the collaboration of patients and healthcare practitioners. Representatives of all groups are included in the coordination group. They are the foundation of the office and the future life sciences strategy, together with industry and academia.

What is your primary role; an expert group, opinion makers or a working group?

None of those actually. We are a coordination group and I work for collaboration.

What is the state of Life sciences-Sweden?

– Life sciences has attracted positive and intense attention lately, and the awareness of this field is high. Internationally, we are very attractive, acknowledged for quality and creativity. However, we are not doing particularly well in the field of solutions for the entire data infrastructure and collection and use of data, and I mean all data. Our records and biobanks, health and health care data, health records, etc. These fields call for improvements if we are to lead the development towards more and more efficient follow-up and access to real-time information.

When will your work be finished?

– This is not a one-off effort but long-term work. We are now looking into the formal structures that are necessary to launch the strategy process next year. We must find a common pace because many regions are currently working with strategies and we are working on a national structure, but those looking at Sweden from outside will observe a need for coherence. We need to send a consistent message internationally,” says Jenni Nordborg.

THE COORDINATION GROUP FOR LIFE SCIENCE

  • President: Anders Lönnberg
  • Göran Ando, former Chairman of the Board, Novo Nordisk
  • Carl Bennet, Chairman of the Board, Getinge
  • Anders Blanck, CEO of Lif
  • Helen Dannetun, Head of Linköping University
  • Jonas Ekstrand, CEO of Sweden Bio
  • Anders Henriksson, Vice Chairman, SKL
  • Darja Isaksson, Director General, Vinnova.
  • Elisabeth Björk, Vice President, AstraZeneca
  • Hannie Lundgren, Research and Innovation Director, Region Skåne
  • Lars Liljedahl, Care Manager, Östersund
  • Lotta Ljungqvist, CEO of GE, Nordic Region
  • Ann-Sofie Lodin, Regional Director, Västra Götaland
  • Ole Petter Ottersen, Head of Karolinska Institutet
  • Sara Riggare, Engineer & Researcher, Karolinska Institutet and Patient.
  • Anna Lefevre Skjöldebrand, CEO of Swedish Medtech
  • Heidi Stensmyren, Federal Chairman of the Swedish Medical Association (Svenska Läkarförbundet)
  • Anna Nilsson Vindefjärd, Secretary General, Research Sweden (Forska Sverige)
  • Mikael Wiberg, Director of Research and Education, Västerbotten County Council
Håll dig uppdaterad med Life Science Sweden

Jag accepterar Nordiske Mediers villkor och avtal

Är du prenumerant? Bli prenumerant

Med en prenumeration får du obegränsad tillgång till webbtidningen. Läs webbtidningen online.

Kommentarer (0)

JOBB I FOKUS

Startsidan just nu

Life Science Sweden tar sommarledigt

Vi på redaktionen går på semester och är tillbaka den 3 augusti. Vi hoppas att ni får en riktigt trevlig sommar! 

Jobb & karriär
Flera förändringar i Oncopeptides ledning

Rockad och nyrekrytering karaktäriserar bolagets tillsättning av ny vd samt forskningschef.

Regeringen tillsätter coronakommission

Finans
Lipigons nyemission övertecknad

Studie: Fler skulle kunna vara immuna mot covid-19

Preliminära resultat pekar på att fler kan vara immuna mot covid-19, även om de fått negativt antikroppssvar.

Nyhetsbrev

Gileads besked – så mycket kommer remdesivir kosta

Priset för att behandla en covid-19-patient med remdesvir landar på 21 800 kronor. – Det är lite lägre än vad jag trodde, säger Anders Sönnerborg till Life Science Sweden.

Arkiv
2

Krönika
Torgny Fornstedt: Analytisk kemi måste hitta tillbaka till sina rötter

Det behövs fler kunniga analytiska kemister både på universiteten och inom industrin, skriver Torgny Fornstedt i en krönika.

Rekordmånga läser Life Science Sweden

Intresset för tidningen har ökat kraftigt. Under våren har antalet besökare tredubblats.

Keminyheter
Sverige vill ha en EU-gemensam kemikaliestrategi

Lovande resultat för oral terapi vid atopiskt eksem

Jobb & karriär
Mattias Bergqvist ny ledamot i Scandinavian CRO

Atrogi får anslag för fetmaforskning

Forskningsföretaget Atrogi har fått ett anslag från Eurostar för utveckling av en substans mot fetma.

LSS in English
Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Remdesivir på väg mot EU-godkännande

Det europeiska läkemedelsverket EMA:s vetenskapliga kommitté rekommenderar remdesivir för godkännande för behandling av covid-19.

Finans
Aegirbio debuterar på Nasdaq First North

2

Ledare
Samuel Lagercrantz: Bergström bra val som vaccinsamordnare

Valet av Richard Bergström som vaccinsamordnare för covid-19 är glädjande, skriver Life Science Swedens chefredaktör Samuel Lagercrantz i en kommentar till gårdagens besked.

Stor genomslagskraft för immunterapi i Sverige

Internationell uppståndelse kring Tegnells sommarprat

Utländska medier har uppmärksammat Anders Tegnells uttalande där han beskriver andra länders agerande kring coronapandemin som ”galenskap”.

Keminyheter
Rötter och grenar blir vårdkläder

2

Tom Britton: ”Nivån för flockimmunitet är lägre än vad vi trott”

Nya matematiska modeller pekar på att flockimmunitetsnivån är kraftigt lägre än vad man tidigare trott, och att immuniteten i dagsläget spelar en större roll, enligt en ny rapport.

Vitalis blir digital konferens

Jobb & karriär
Maja Johansson blir chef för nya vaccinanläggningen i Umeå

Sedan en månad tillbaka är Maja Johansson ny site manager för Diamyd Medicals nya tillverkningsenhet i Umeå.

Remdesivir ges till barn med covid-19 i ny studie

Finans
Avgiften för klinisk läkemedelsprövning ökar med 250 procent

Ansökningsavgiften för kliniska prövningar höjs från 50 000 kronor till 123 000–148 000 kronor till följd av en ny EU-förordning, enligt rapport från Läkemedelsverket.

Selectimmune rekryterar ny vd

Tillväxtanalys ska bevaka life-science industrins utveckling

Vinnova stödjer KTH:s testkit för antikroppar mot covid-19

Jobb & karriär
Abigo nyanställer

Elektas vd avgår med omedelbar verkan

Ansiktsmask krävs för covidskydd enligt Science-artikel

Jobb & karriär
Cellavision tappar vd

Keminyheter
Kemikalieinspektionen i topp i arbetsplatsranking

1

Apotea och Werlabs säljer antikroppstest för covid-19

Läkemedelsverket förbjuder ett till covidtest

Röntgen visar hur coronaviruset förökar sig

Jobb & karriär
Micropos får ny vd

Se alla Medlemsnytt

Cobra signs supply agreement with AstraZeneca

Ny medarbetare till PharmaRelations i Norge

PharmaRelations stärker upp med ny konsultchef

Join us for a webinar on confocal microscopy!

3D Scanning Systems - Innovative Solutions for 3D digitizin

Akut produktion av desinfektionsmedel med hjälp av Busch

Improve your metrology skills, also @home.

Leverans av Busch vakuumsystem till Brasilien

Cleaning and Disinfecting Microscope and Optical Components

Busch Vakuum Solutions levererar till sjukhus i Palestina

Are you working from home?

Busch Vacuum Solutions levererar till sjukhustrailers i USA

Centralisering av vakuum från Busch Vacuum Solutions

Increase efficiency in the lab!

Verifiering vid tillverkning av Ventilatorer

Busch levererar vakuumsystem till akutsjukhus i Madrid

Samarbete mellan Busch i Schweiz och Frankrike mot Corona

Rening av gaser med vakuumteknik från Busch Vacuum Solutions

Optimize measurement plans remotely with free ZEISS CALYPSO

Find what you need from the ZEISS Industrial Quality world.

Biofiltrering med Busch TYR Blåsmaskin

Ny Country Manager PharmaRelations Norge

Perfekt packad skinka med vakuum från Busch

Last week, we introduced ZEISS Lightsheet 7.

Fiskodling med vakuum från Busch Vacuum Solutions

Sänd till en kollega

0.172